Home>
US Stocks>
Aurinia Pharmaceuticals

Aurinia Pharmaceuticals share price today

(AUPH)

Aurinia Pharmaceuticals share price is $8.98 & ₹765.08 as on 25 Dec 2024, 2.30 'hrs' IST

$8.98

▲

0.03

(0.34%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Aurinia Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Aurinia Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Aurinia Pharmaceuticals. Get details on the Indian mutual funds that are investing in Aurinia Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Aurinia Pharmaceuticals's financials.

Aurinia Pharmaceuticals share price movements

Today's Low: $8.90
Today's High: $9.01
$8.98
0.89%
Downside
Day's Volatility :1.17%
Upside
0.28%
52 Weeks Low: $4.71
52 Weeks High: $10.67
$8.98
47.55%
Downside
52 Weeks Volatility :55.86%
Upside
15.84%

Aurinia Pharmaceuticals Returns

Period	Aurinia Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	25.42%	-8.7%	0.0%
6 Months	59.79%	-5.0%	0.0%
1 Year	-3.34%	3.2%	0.0%
3 Years	-62.44%	0.0%	-21.1%

Aurinia Pharmaceuticals Key Statistics

in dollars & INR

Previous Close	$8.95
Open	$8.99
Today's High	$9.005
Today's Low	$8.9
Market Capitalization	$1.3B
Today's Volume	$485.8K
52 Week High	$10.67
52 Week Low	$4.71
Revenue TTM	$220.4M
EBITDA	$495.0K
Earnings Per Share (EPS)	$-0.15
Profit Margin	-10.23%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-5.78%

How to invest in Aurinia Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Aurinia Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aurinia Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aurinia Pharmaceuticals or AUPH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aurinia Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aurinia Pharmaceuticals shares which would translate to 0.095 fractional shares of Aurinia Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aurinia Pharmaceuticals, in just a few clicks!

Returns in Aurinia Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

Aurinia Pharmaceuticals investment value today

Current value as on today

₹99,089

Returns

₹911

(-0.91%)

Returns from Aurinia Pharmaceuticals Stock

₹3,337 (-3.34%)

Dollar Returns

₹2,426 (+2.43%)

Indian investors sentiment towards Aurinia Pharmaceuticals

-13%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Aurinia Pharmaceuticals on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -13% less investors are searching Aurinia Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Aurinia Pharmaceuticals

BlackRock Inc
6.48%
Armistice Capital, LLC
5.73%
TANG CAPITAL MANAGEMENT LLC
5.05%
NEA Management Company, LLC
2.77%
State Street Corp
2.06%
Goldman Sachs Group Inc
1.68%

Analyst Recommendation on Aurinia Pharmaceuticals

Buy

84%Buy

15%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Aurinia Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Aurinia Pharmaceuticals

What analysts predicted

Upside of 20.66%

Current:

$8.98

Target:

$10.84

Insights on Aurinia Pharmaceuticals

Price Movement
In the last 6 months, AUPH stock has moved up by 61.2%
Increasing Revenue
Revenue is up for the last 4 quarters, 45.09M → 67.77M (in $), with an average increase of 12.7% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -26.87M → 14.35M (in $), with an average increase of 611.3% per quarter
AUPH vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.3% return, outperforming this stock by 29.7%
AUPH vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 86.2%
Price to Sales
ForAUPH every $1 of sales, investors are willing to pay $5.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Aurinia Pharmaceuticals Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$463.0K	↑ 10.24%
Net Income	$-64.1M	↓ 9.42%
Net Profit Margin	-13.8K%	↑ 3006.43%

	FY19	Y/Y Change
Revenue	$318.0K	↓ 31.32%
Net Income	$-123.8M	↑ 93.15%
Net Profit Margin	-38.9K%	↓ 25096.47%

	FY20	Y/Y Change
Revenue	$50.1M	↑ 15660.38%
Net Income	$-102.7M	↓ 17.09%
Net Profit Margin	-204.88%	↑ 38740.4%

	FY21	Y/Y Change
Revenue	$45.6M	↓ 9.0%
Net Income	$-181.0M	↑ 76.24%
Net Profit Margin	-396.81%	↓ 191.93%

	FY22	Y/Y Change
Revenue	$134.0M	↑ 193.89%
Net Income	$-108.2M	↓ 40.22%
Net Profit Margin	-80.71%	↑ 316.1%

	FY23	Y/Y Change
Revenue	$175.5M	↑ 30.95%
Net Income	$-78.0M	↓ 27.88%
Net Profit Margin	-44.45%	↑ 36.26%

	Q2 FY23	Q/Q Change
Revenue	$41.5M	↑ 20.59%
Net Income	$-11.5M	↓ 56.15%
Net Profit Margin	-27.7%	↑ 48.46%

	Q3 FY23	Q/Q Change
Revenue	$54.5M	↑ 31.38%
Net Income	$-13.4M	↑ 17.01%
Net Profit Margin	-24.67%	↑ 3.03%

	Q4 FY23	Q/Q Change
Revenue	$45.1M	↓ 17.28%
Net Income	$-26.9M	↑ 99.86%
Net Profit Margin	-59.6%	↓ 34.93%

	Q1 FY24	Q/Q Change
Revenue	$50.3M	↑ 11.55%
Net Income	$-10.7M	↓ 60.0%
Net Profit Margin	-21.37%	↑ 38.23%

	Q2 FY24	Q/Q Change
Revenue	$57.2M	↑ 13.7%
Net Income	$722.0K	↓ 106.72%
Net Profit Margin	1.26%	↑ 22.63%

	Q3 FY24	Q/Q Change
Revenue	$67.8M	↑ 18.5%
Net Income	$14.4M	↑ 1887.53%
Net Profit Margin	21.17%	↑ 19.91%

	FY18	Y/Y Change
Profit	$-40.9M	↓ 9865.87%

	FY19	Y/Y Change
Profit	$-52.5M	↑ 28.42%

	FY20	Y/Y Change
Profit	$-209.0K	↓ 99.6%

	FY21	Y/Y Change
Profit	$44.5M	↓ 21398.56%

	FY22	Y/Y Change
Profit	$128.4M	↑ 188.37%

	FY23	Y/Y Change
Profit	$161.4M	↑ 25.71%

	Q2 FY23	Q/Q Change
Profit	$39.9M	↑ 17.49%

	Q3 FY23	Q/Q Change
Profit	$47.7M	↑ 19.57%

	Q4 FY23	Q/Q Change
Profit	$39.7M	↓ 16.85%

	Q1 FY24	Q/Q Change
Profit	$42.6M	↑ 7.18%

	Q2 FY24	Q/Q Change
Profit	$48.3M	↑ 13.47%

	Q3 FY24	Q/Q Change
Profit	$61.7M	↑ 27.86%

	FY18	Y/Y Change
Operating Cash Flow	$-51.6M	↑ 25.36%
Investing Cash Flow	$-65.0K	↓ 99.19%
Financing Cash Flow	$4.0M	↓ 97.71%

	FY19	Y/Y Change
Operating Cash Flow	$-63.5M	↑ 22.95%
Investing Cash Flow	$7.8M	↓ 12073.85%
Financing Cash Flow	$243.7M	↑ 5971.95%

	FY20	Y/Y Change
Operating Cash Flow	$-69.9M	↑ 10.09%
Investing Cash Flow	$-158.2M	↓ 2132.46%
Financing Cash Flow	$194.4M	↓ 20.25%

	FY21	Y/Y Change
Operating Cash Flow	$-157.7M	↑ 125.73%
Investing Cash Flow	$-103.9M	↓ 34.34%
Financing Cash Flow	$221.1M	↑ 13.76%

	FY22	Y/Y Change
Operating Cash Flow	$-79.5M	↓ 49.57%
Investing Cash Flow	$-60.6M	↓ 41.63%
Financing Cash Flow	$2.4M	↓ 98.9%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-2.8M	↓ 91.08%
Investing Cash Flow	$-5.6M	↓ 122.56%
Financing Cash Flow	$1.1M	↓ 30.45%

Aurinia Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Aurinia Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Aurinia Pharmaceuticals Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Aurinia Pharmaceuticals Inc	3.1%	59.79%	-3.34%	-62.44%	-55.63%
Regeneron Pharmaceuticals, Inc.	-4.68%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-5.49%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.08%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-11.59%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Aurinia Pharmaceuticals Inc	NA	NA	0.0	0.03	-0.06	-0.02	NA	2.71
Regeneron Pharmaceuticals, Inc.	17.7	17.7	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Aurinia Pharmaceuticals Inc	Buy	$1.3B	-55.63%	NA	-10.23%
Regeneron Pharmaceuticals, Inc.	Buy	$78.6B	91.19%	17.7	33.61%
Biontech Se	Buy	$27.2B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.2B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$104.4B	86.41%	32.84	-4.51%

About Aurinia Pharmaceuticals

aurinia pharmaceuticals is a biotechnology company located in 5120-75 street, edmonton, canada.

Organization	Aurinia Pharmaceuticals
Employees	300
CEO	Mr. Peter S. Greenleaf M.B.A.
Industry	Health Technology

Management People of Aurinia Pharmaceuticals

Name	Title
Mr. Peter S. Greenleaf M.B.A.	CEO & Director
Mr. Joseph M. Miller CPA	Chief Financial Officer
Mr. Matthew Maxwell Donley M.B.A.	Chief Operations Officer
Mr. Stephen P. Robertson	Executive Vice President of General Counsel
Ms. Andrea Levin Christopher	Head of the Corporate Communications & Investor Relations
Mr. Michael R. Martin	Chief Business Officer
Ms. Sue Evans	Senior Vice President of Global Regulatory Affairs
Dr. Gregory F. Keenan M.D.	Chief Medical Officer
Dr. Premchandran Ramiya Ph.D.	Senior Vice President of Manufacturing & Supply Chain
Ms. DeDe Sheel	Vice President of Investor Relation

Important FAQs about investing in Aurinia Pharmaceuticals from India :

What is Aurinia Pharmaceuticals share price today?

Aurinia Pharmaceuticals share price today stands at $8.98, Open: $8.99 ; Previous Close: $8.95 ; High: $9.01 ; Low: $8.90 ; 52 Week High: $10.67 ; 52 Week Low: $4.71. The stock opens at $8.99, after a previous close of $8.95. The stock reached a daily high of $9.01 and a low of $8.90, with a 52-week high of $10.67 and a 52-week low of $4.71.

Can Indians buy Aurinia Pharmaceuticals shares?

Yes, Indians can invest in the Aurinia Pharmaceuticals (AUPH) from India.

With INDmoney, you can buy Aurinia Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Aurinia Pharmaceuticals at zero transaction cost.

How can I buy Aurinia Pharmaceuticals shares from India?

It is very easy to buy Aurinia Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aurinia Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Aurinia Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Aurinia Pharmaceuticals stocks?

To start investing in Aurinia Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.